Search research articles
Contact Us
Filters
Showing results (21-30 of 62) with videos related to
Page
of 7
Sort By:
Drugs Under Experimental and Clinical Research
|
January 1, 1985
Experimental efficacy and pharmacokinetic properties of cefpiramide, a new cephalosporin
K P Fu, T Vince, S McCloud, et al.
Thrombosis and Haemostasis
|
June 28, 1990
Deglycosylation increases the fibrinolytic activity of a deletion mutant of tissue-type plasminogen activator
J Wilhelm, N K Kalyan, S G Lee, et al.
Virology
|
August 1, 1990
Coexpression of biologically active simian immunodeficiency virus (SIV) Rev and Env in an SV40 system: the SIV rev gene regulates env expression
S M Cheng, M Blume, S G Lee, et al.
Thrombosis Research
|
April 1, 1988
Disposition of a novel recombinant tissue plasminogen activator, delta 2-89 TPA, in mice
K P Fu, S Lee, W T Hum, et al.
Journal of Medical Primatology
|
January 1, 1990
The simian immunodeficiency virus (SIV) rev gene regulates env expression
S M Cheng, M Blume, S G Lee, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 1, 1981
Expression in Escherichia coli of biologically active enzyme by a DNA sequence coding for the human plasminogen activator urokinase
B Ratzkin, S G Lee, W J Schrenk, et al.
Vaccine
|
June 1, 1994
Relevance of the guinea-pig necrotic inflammation footpad reaction to safety concerns with MDP-based adjuvants
R N Hjorth, G M Bonde, E D Piner, et al.
Vaccine
|
July 1, 1991
Evaluation of adenovirus type 4 and type 7 recombinant hepatitis B vaccines in dogs
M Chengalvala, M D Lubeck, A R Davis, et al.
Clinical Pharmacology and Therapeutics
|
October 1, 1993
Colchicine disposition in human leukocytes after single and multiple oral administration
O N Chappey, E Niel, J L Wautier, et al.
Gene
|
December 7, 1989
Synthesis and refolding of human tissue-type plasminogen activator in Bacillus subtilis
L F Wang, W T Hum, N K Kalyan, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 62) with videos related to
Sort By:
Page
of 7
Drugs Under Experimental and Clinical Research
|
January 1, 1985
Experimental efficacy and pharmacokinetic properties of cefpiramide, a new cephalosporin
K P Fu, T Vince, S McCloud, et al.
Thrombosis and Haemostasis
|
June 28, 1990
Deglycosylation increases the fibrinolytic activity of a deletion mutant of tissue-type plasminogen activator
J Wilhelm, N K Kalyan, S G Lee, et al.
Virology
|
August 1, 1990
Coexpression of biologically active simian immunodeficiency virus (SIV) Rev and Env in an SV40 system: the SIV rev gene regulates env expression
S M Cheng, M Blume, S G Lee, et al.
Thrombosis Research
|
April 1, 1988
Disposition of a novel recombinant tissue plasminogen activator, delta 2-89 TPA, in mice
K P Fu, S Lee, W T Hum, et al.
Journal of Medical Primatology
|
January 1, 1990
The simian immunodeficiency virus (SIV) rev gene regulates env expression
S M Cheng, M Blume, S G Lee, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 1, 1981
Expression in Escherichia coli of biologically active enzyme by a DNA sequence coding for the human plasminogen activator urokinase
B Ratzkin, S G Lee, W J Schrenk, et al.
Vaccine
|
June 1, 1994
Relevance of the guinea-pig necrotic inflammation footpad reaction to safety concerns with MDP-based adjuvants
R N Hjorth, G M Bonde, E D Piner, et al.
Vaccine
|
July 1, 1991
Evaluation of adenovirus type 4 and type 7 recombinant hepatitis B vaccines in dogs
M Chengalvala, M D Lubeck, A R Davis, et al.
Clinical Pharmacology and Therapeutics
|
October 1, 1993
Colchicine disposition in human leukocytes after single and multiple oral administration
O N Chappey, E Niel, J L Wautier, et al.
Gene
|
December 7, 1989
Synthesis and refolding of human tissue-type plasminogen activator in Bacillus subtilis
L F Wang, W T Hum, N K Kalyan, et al.
Page
of 7